Yongai Yu

State Key Laboratory Of Fine Chemicals
Dalian, 116024, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Cooperative Ir(III)/Ni(II) catalysis in a photoactive molecular amine cage for visible-light-induced aerobic α-hydroxylation of β-keto esters.

Cooperative Ir(III)/Ni(II) catalysis in a photoactive molecular amine cage for visible-light-induced aerobic α-hydroxylation of β-keto esters.

Journal: Chemical communications (Cambridge, England)
Published: June 16, 2026

Natural Polymer-Based Hemostatic Hydrogels with Advanced Material and Structural Designs for Functional Applications.

Natural Polymer-Based Hemostatic Hydrogels with Advanced Material and Structural Designs for Functional Applications.

Journal: Pharmaceutics
Published: June 06, 2026

Confining ultrasmall Au nanoclusters in an ionic Ir(iii)-based cage for selective photoreduction.

Confining ultrasmall Au nanoclusters in an ionic Ir(iii)-based cage for selective photoreduction.

Journal: Chemical science
Published: February 15, 2026

A study on the correlation between albumin-to-alkaline phosphatase ratio and the severity of pelvic inflammatory disease.

A study on the correlation between albumin-to-alkaline phosphatase ratio and the severity of pelvic inflammatory disease.

Journal: Frontiers in medicine
Published: October 19, 2025

Predictive value of the KELIM in neoadjuvant treatment for patients with advanced ovarian cancer.

Predictive value of the KELIM in neoadjuvant treatment for patients with advanced ovarian cancer.

Journal: Frontiers in oncology
Published: July 31, 2025

Efficacy and safety analyses of bevacizumab in neoadjuvant chemotherapy for ovarian cancer: a systematic review and meta-analysis.

Efficacy and safety analyses of bevacizumab in neoadjuvant chemotherapy for ovarian cancer: a systematic review and meta-analysis.

Journal: Frontiers in pharmacology
Published: February 22, 2025

Efficacy and safety of mirvetuximab soravtansine in recurrent ovarian cancer with FRa positive expression: A systematic review and meta-analysis.

Efficacy and safety of mirvetuximab soravtansine in recurrent ovarian cancer with FRa positive expression: A systematic review and meta-analysis.

Journal: Critical reviews in oncology/hematology
Published: September 20, 2023

Mucins and mucinous ovarian carcinoma: Development, differential diagnosis, and treatment.

Mucins and mucinous ovarian carcinoma: Development, differential diagnosis, and treatment.

Journal: Heliyon
Published: July 19, 2023

Efficacy and safety of PD-1/PD-L1 inhibitors in the treatment of recurrent and refractory ovarian cancer: A systematic review and a meta-analysis.

Efficacy and safety of PD-1/PD-L1 inhibitors in the treatment of recurrent and refractory ovarian cancer: A systematic review and a meta-analysis.

Journal: Frontiers in pharmacology
Published: November 29, 2022

Efficacy and Safety of Minimally Invasive Surgery Versus Open Laparotomy for Interval Debulking Surgery of Advanced Ovarian Cancer After Neoadjuvant Chemotherapy: A Systematic Review and A Meta-Analysis.

Efficacy and Safety of Minimally Invasive Surgery Versus Open Laparotomy for Interval Debulking Surgery of Advanced Ovarian Cancer After Neoadjuvant Chemotherapy: A Systematic Review and A Meta-Analysis.

Journal: Frontiers in oncology
Published: March 20, 2022
Showing 1-10 of 10

Last Updated: 09/26/2026